FlexiVex
FlexiVex is a fast-acting, clinically validated anti-inflammatory supplement
featuring ApresFlex®, a patented Boswellia serrata extract standardized to
20% 3-O-Acetyl-11-Keto-β-Boswellic Acid (AKBA). ApresFlex supports joint
comfort, reduces inflammation, and promotes cartilage health.
Built on Quality and Intention
Every Nutravexa formula reflects our commitment to ingredient integrity, careful sourcing, and responsible manufacturing. We focus on clean formulations and meaningful support without unnecessary fillers or inflated claims.
• Clinically Studied Ingredients
• Manufactured in cGMP Certified Facilities
• No Unnecessary Additives
Reduces joint pain and stiffness in as little as 5 days
• Up to 70% reduction in WOMAC pain scores by 90 days
• Improves flexibility, joint function, and mobility
• Inhibits key inflammatory enzymes (MMP-3, TNF-α, IL-6)
• Clinically shown to protect cartilage and maintain joint space
• Vegetarian, Non-GMO, no preservatives, dairy, wheat, or sugar
• 30 vegetarian capsules per bottle
• cGMP, FDA-registered U.S. facility
Karlapudi et al. (2022, JANA): At 100 mg/day, ApresFlex significantly
reduced VAS, LFI, and WOMAC scores within 5 days, and showed up to 70%
pain reduction by 90 days.
• Dubey et al. (2024, EXPLORE Journal): Meta-analysis confirms ApresFlex
outperforms other Boswellia extracts in reducing pain, stiffness, and
preserving cartilage.
• Sengupta et al. (2010, Int. J. Med. Sci.): Aflapin® (ApresFlex) outperformed
5-Loxin in reducing inflammation, MMP-3, ICAM-1, and improving joint
function.
• MRI evidence: Preserves cartilage thickness and joint space; reduces
biomarkers of degradation (MMP-3, CRP, IL-6).
• Health Canada Claims: Approved for reducing osteoarthritis pain,
protecting cartilage, improving mobility, and joint comfort.
Recommended Dosage: 1 capsule daily before meals with water
• Noticeable results in 5–7 days, continued improvement over 3–6 months
• Clinically safe for long-term daily use
• No serious adverse events reported
• No toxicity at doses > 2500 mg/kg in animal models
• No genotoxicity, mutagenicity, or organ damage observed in clinical trials
• Warning: Keep out of reach of children
Powered by ApresFlex®, the most clinically studied Boswellia
extract for joint health
• Low-dose (100 mg/day) with fast-acting 5-day relief, unlike
standard extracts
• Reduces inflammatory markers and preserves cartilage per MRI
and biomarker studies
• Ideal for patients with osteoarthritis, joint inflammation, or stiffness
due to aging or overuse
NUT